fbpx
All about COVID19 - An initiative from WhiteCoats that brings together updates from top curated resources exclusively for healthcare professionals

A recent study published supports the use of tetracycline as an immunomodulatory drug for COVID-19. These drugs have an anti-inflammatory effect and a broad-spectrum antibacterial activity. These drugs have been very useful in treating HIV and malaria. Their ability to suppress the proliferation of T cells and decrease the production of inflammation-signalling molecules is something that helps in the process. ...

Different approaches have been put into action to come up with a vaccine for the recent virus that has caused havoc. Hence, scientists are looking for passive protection that can help protect against the virus and can be useful for temporary purposes. In the process, scientists have come up with the discovery of an antigen to elicit neutralizing antibody responses. ...

The worldwide pharmaceutical industry is on a hunt for a vaccine for COVID-19 but tests for better effectiveness against the virus are also in the process. In a recent study, it was seen that extract from edible seaweed significantly performed better than remdesivir, the current standard antiviral used as a vaccine. Heparin which is a frequently used blood thinner and ...

Experts around the world have predicted that the pandemic may see a repeated wave which is why scientists worldwide have been trying to find a vaccine or an antiviral that can protect the people against the virus and reduce the number of deaths and cases next time. A new study reports the use of the Newcastle disease virus as a ...

A new study shows that the olfactory cell types are most vulnerable to infection by the novel coronavirus. The sensory neurons that are involved in detecting and transmitting the sense of smell to the brain are not vulnerable cell types. Loss of smell also known as anosmia is the most commonly reported indicator of COVID-19 infection. It is said to ...

The rise of the pandemic has put forth a clear idea that wearing masks and social distancing can be effective in preventing transmission of coronavirus if followed thoroughly. An analysis based on 194 countries showed that places without thorough mask-wearing practices saw a 55% weekly increase in deaths per capita after the first case was reported on a comparison with ...

Preliminary findings from a study show that immunotherapy for cancer patients for COVID-19 is considered safe and it doesn’t worsen the complications. This data has been brought to light by Layne Weatherford, Ph.D., one of the scientists working on the COVID-19 research. COVID-19 complications result from an overcharged immune response that leads to an increased production of proteins called cytokines. ...

It has come to light, in a recent study that, droplets from a cough or a sneeze without a mask can travel farther and last longer in humid, cold climates than in hot according to a study on droplet physics by a team of international engineers. Researchers incorporated the understanding of environmental factors like the climate, the rains, etc. on ...

Researchers who conducted the first clinical trial for Hydroxychloroquine as an early treatment for mild coronavirus illness have found that the drug was no better than a placebo in non-hospitalized patients. About 24% of the patients were given Hydroxychloroquine for over 14 days and about 30% of the patients were given placebo, both with persisting symptoms showed no significant difference ...

Researchers from Munich and Ulm have been trying to understand the virus better and have determined how coronavirus SARS-CoV-2 inhibits the synthesis of proteins in infected cells and effectively disarms the body's innate immune system. This Nonstructural Protein 1 (Nsp1) encoded by the coronavirus SARS-Cov-2 has been revealed to have a damaging effect on host cells. It is one of ...